Evidence for a human leucocyte antigen-DM-induced structural change in human leucocyte antigen-DOβ

Immunology

Volumn 127, Issue 3, 2009, Pages 408-417

  Deshaies, Francis ^a   Diallo, Djibril A ^a   Fortin, Jean Simon ^a   O'Rourke, Helen M ^b   Pezeshki, Abdul Mohammad ^a   Bellemare Pelletier, Angélique ^a   Raby, Nicola ^a   Bédard, Nathalie ^a   Brunet, Alexandre ^a   Denzin, Lisa K ^b   Thibodeau, Jacques ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Weill Cornell Graduate School of Biomedical Sciences   (United States)

Author keywords

Antigen presentation; Antigen processing; B cells; Human; Major histocompatibility complex

Indexed keywords

HLA DM ANTIGEN; HLA DO ANTIGEN; HLA DOBETA ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MAGS.DO5; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN STRUCTURE; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FOLDING;

ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; B-LYMPHOCYTES; ENDOPLASMIC RETICULUM; EPITOPES, B-LYMPHOCYTE; HELA CELLS; HLA-D ANTIGENS; HUMANS; PROTEIN FOLDING; TRANSFECTION;

EID: 66549117520     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2008.02984.x     Document Type: Article

References (62)

1. Cresswell P. Assembly, transport, and function of MHC class-II molecules. Annu Rev Immunol 1994 12 : 259 93.
2. Bakke O, Dobberstein B. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 1990 63 : 707 16.
3. Lotteau V, Teyton L, Peleraux A et al. Intracellular transport of class II MHC molecules directed by invariant chain. Nature 1990 348 : 600 5.
4. Roche PA, Cresswell P. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 1990 345 : 615 8.
5. Roche PA, Cresswell P. Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc Natl Acad Sci USA 1991 88 : 3150 4.
6. Ghosh P, Amaya M, Mellins E, Wiley DC. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 1995 378 : 457 62.
7. Sloan VS, Cameron P, Porter G, Gammon M, Amaya M, Mellins E, Zaller DM. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 1995 375 : 802 6.
8. Denzin LK, Robbins NF, Carboy-Newcomb C, Cresswell P. Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. Immunity 1994 1 : 595 606.
9. Weber DA, Evavold BD, Jensen PE. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 1996 274 : 618 20.
10. Mosyak L, Zaller DM, Wiley DC. The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation. Immunity 1998 9 : 377 83.
11. Sanderson F, Powis SH, Kelly AP, Trowsdale J. Limited polymorphism in HLA-DM does not involve the peptide binding groove. Immunogenetics 1994 39 : 56 8.
12. Fremont DH, Crawford F, Marrack P, Hendrickson WA, Kappler J. Crystal structure of mouse H2-M. Immunity 1998 9 : 385 93.
13. Katz JF, Stebbins C, Appella E, Sant AJ. Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules. J Exp Med 1996 184 : 1747 53.
14. Kropshofer H, Vogt AB, Moldenhauer G, Hammer J, Blum JS, Hammerling GJ. Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J 1996 15 : 6144 54.
15. Van Ham SM, Grueneberg U, Malcherek G, Broeker I, Melms A, Trowsdale J. Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs. J Exp Med 1996 184 : 2019 24.
16. Denzin LK, Hammond C, Cresswell P. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J Exp Med 1996 184 : 2153 65.
17. Kropshofer H, Arndt SO, Moldenhauer G, Hammerling GJ, Vogt AB. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity 1997 6 : 293 302. (Pubitemid 27148596)
18. Vogt AB, Moldenhauer G, Hammerling GJ, Kropshofer H. HLA-DM stabilizes empty HLA-DR molecules in a chaperone-like fashion. Immunol Lett 1997 57 : 209 11.
19. Stratikos E, Wiley DC, Stern LJ. Enhanced catalytic action of HLA-DM on the exchange of peptides lacking backbone hydrogen bonds between their N-terminal region and the MHC class II alpha-chain. J Immunol 2004 172 : 1109 17.
20. Natarajan SK, Stern LJ, Sadegh-Nasseri S. Sodium dodecyl sulfate stability of HLA-DR1 complexes correlates with burial of hydrophobic residues in pocket 1. J Immunol 1999 162 : 3463 70.
21. Weber DA, Dao CT, Jun J, Wigal JL, Jensen PE. Transmembrane domain-mediated colocalization of HLA-DM and HLA-DR is required for optimal HLA-DM catalytic activity. J Immunol 2001 167 : 5167 74.
22. Narayan K, Chou CL, Kim A, Hartman IZ, Dalai S, Khoruzhenko S, Sadegh-Nasseri S. HLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes. Nat Immunol 2007 8 : 92 100. (Pubitemid 46242363)
23. Rotzschke O, Lau JM, Hofstatter M, Falk K, Strominger JL. A pH-sensitive histidine residue as control element for ligand release from HLA-DR molecules. Proc Natl Acad Sci USA 2002 99 : 16946 50.
24. Busch R, Reich Z, Zaller DM, Sloan V, Mellins ED. Secondary structure composition and pH-dependent conformational changes of soluble recombinant HLA-DM. J Biol Chem 1998 273 : 27557 64.
25. Ullrich HJ, Doring K, Grueneberg U, Jaehnig F, Trowsdale J, Van Ham MS. Interaction between HLA-DM and HLA-DR involves regions that undergo conformational changes at lysosomal pH. Proc Natl Acad Sci USA 1997 94 : 13163 8.
26. Chou CL, Sadegh-Nasseri S. HLA-DM recognizes the flexible conformation of major histocompatibility complex class II. J Exp Med 2000 192 : 1697 706.
27. Doebele CR, Busch R, Scott MH, Pashine A, Mellins DE. Determination of the HLA-DM interaction site on HLA-DR molecules. Immunity 2000 13 : 517 27.
28. Pashine A, Busch R, Belmares MP et al. Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides. Immunity 2003 19 : 183 92.
29. Liljedahl M, Kuwana T, Fung-Leung WP, Jackson M, Peterson PA, Karlsson L. HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. EMBO J 1996 15 : 4817 24.
30. Denzin LK, Sant'Angelo DB, Hammond C, Surman MJ, Cresswell P. Negative regulation by HLA-DO of MHC Class II-restricted antigen processing. Science 1997 278 : 106 9.
31. Van Ham SM, Tjin EPM, Lillemeier BF et al. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading. Curr Biol 1997 7 : 950 7.
32. Brocke P, Armandola E, Garbi N, Hammerling GJ. Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes. Eur J Immunol 2003 33 : 411 21.
33. Liljedahl M, Winqvist O, Surh CD et al. Altered antigen presentation in mice lacking H2-O. Immunity 1998 8 : 233 43.
34. Perraudeau M, Taylor PR, Stauss HJ et al. Altered major histocompatibility complex class II peptide loading in H2-O-deficient mice. Eur J Immunol 2000 30 : 2871 80.
35. Fallas JL, Tobin HM, Lou O, Guo D, Sant'Angelo DB, Denzin LK. Ectopic expression of HLA-DO in mouse dendritic cells diminishes MHC class II antigen presentation. J Immunol 2004 173 : 1549 60.
36. Kropshofer H, Vogt AB, Thery C et al. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules. EMBO J 1998 17 : 2971 81.
37. Chen X, Reed-Loisel LM, Karlsson L, Jensen PE. H2-O expression in primary dendritic cells. J Immunol 2006 176 : 3548 56.
38. Hornell TM, Burster T, Jahnsen FL et al. Human dendritic cell expression of HLA-DO is subset specific and regulated by maturation. J Immunol 2006 176 : 3536 47.
39. Fallas JL, Yi W, Draghi NA, O'Rourke HM, Denzin LK. Expression patterns of H2-O in mouse B cells and dendritic cells correlate with cell function. J Immunol 2007 178 : 1488 97.
40. van Ham M, van Lith M, Lillemeier B et al. Modulation of the major histocompatibility complex class II-associated peptide repertoire by human histocompatibility leukocyte antigen (HLA)-DO. J Exp Med 2000 191 : 1127 36.
41. Jensen PE. Antigen processing: HLA-DO - a hitchhiking inhibitor of HLA-DM. Curr Biol 1998 8 : R128 31.
42. Douek DC, Altmann DM. HLA-DO is an intracellular class II molecule with distinctive thymic expression. Int Immunol 1997 9 : 355 64.
43. Marquardt T, Helenius A. Misfolding and aggregation of newly synthesized proteins in the endoplasmic reticulum. J Cell Biol 1992 117 : 505 13.
44. Deshaies F, Brunet A, Diallo DA, Denzin LK, Samaan A, Thibodeau J. A point mutation in the groove of HLA-DO allows egress from the endoplasmic reticulum independent of HLA-DM. Proc Natl Acad Sci USA 2005 102 : 6443 8.
45. Brunet A, Samaan A, Deshaies F, Kindt TJ, Thibodeau J. Functional characterization of a lysosomal sorting motif in the cytoplasmic tail of HLA-DObeta. J Biol Chem 2000 275 : 37062 71.
46. Faubert A, Samaan A, Thibodeau J. Functional analysis of tryptophans alpha 62 and beta 120 on HLA-DM. J Biol Chem 2002 277 : 2750 5.
47. Tonnelle C, DeMars R, Long EO. DOb: a new β chain gene in HLA-D with a distinct regulation of expression. EMBO J 1985 4 : 2839 47.
48. Hammond C, Denzin LK, Pan M, Griffith JM, Geuze HJ, Cresswell P. The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules. J Immunol 1998 161 : 3282 91.
49. Khalil H, Deshaies F, Bellemare-Pelletier A, Brunet A, Faubert A, Azar GA, Thibodeau J. Class II transactivator-induced expression of HLA-DOβ in HeLa cells. Tissue Antigens 2002 60 : 372 82.
50. Glazier KS, Hake SB, Tobin HM, Chadburn A, Schattner EJ, Denzin LK. Germinal center B cells regulate their capability to present antigen by modulation of HLA-DO. J Exp Med 2002 195 : 1063 9.
51. Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973 52 : 456 67.
52. Bellemare-Pelletier A, Tremblay J, Beaulieu S et al. HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing. J Leukoc Biol 2005 78 : 95 105. (Pubitemid 40979948)
53. Ogorelkova M, Elahi SM, Gagnon D, Massie B. DNA delivery to cells in culture: generation of adenoviral libraries for high-throughput functional screening. Methods Mol Biol 2004 246 : 15 27.
54. Samaan A, Thibodeau J, Mahana W, Castellino F, Cazenave PA, Kindt TJ. Cellular distribution of a mixed MHC class II heterodimer between DRa and a chimeric DOβ chain. Int Immunol 1999 11 : 99 111. (Pubitemid 29037593)
55. Braunstein NS, Germain RN. Allele-specific control of Ia molecule surface expression and conformation: implications for a general model of Ia structure-function relationship. Proc Natl Acad Sci USA 1987 84 : 2921 5.
56. Bonnerot C, Marks MS, Cosson P, Robertson EJ, Bikoff EK, Germain RN, Bonifacino JS. Association with BiP and aggregation of class II MHC molecules synthesized in the absence of invariant chain. EMBO J 1994 13 : 934 44.
57. van Lith M, Benham AM. The DMalpha and DMbeta chain cooperate in the oxidation and folding of HLA-DM. J Immunol 2006 177 : 5430 9.
58. Braunstein NS, Germain RN, Loney K, Berkowitz N. Structurally interdependent and independent regions of allelic polymorphism in class II MHC molecules: implications for Ia function and evolution. J Immunol 1990 145 : 1635 45.
59. Layet C, Germain RN. Invariant chain promotes egress of poorly expressed, haplotype-mismatched class II major histocompatibility complex AαBβ dimers from the endoplasmic reticulum/cis-Golgi compartment. Proc Natl Acad Sci USA 1991 88 : 2364 50.
60. Serradell L, Muntasell A, Catalfamo M, Marti M, Costa M, De Preval C, Jaraquemada D. HLA-DM can partially replace the invariant chain for HLA-DR transport and surface expression in transfected endocrine epithelial cells. Tissue Antigens 1999 53 : 447 58.
61. Verreck FA, Fargeas CA, Hammerling GJ. Conformational alterations during biosynthesis of HLA-DR3 molecules controlled by invariant chain and HLA-DM. Eur J Immunol 2001 31 : 1029 36.
62. Hansen TH, Lybarger L, Yu L, Mitaksov V, Fremont DH. Recognition of open conformers of classical MHC by chaperones and monoclonal antibodies. Immunol Rev 2005 207 : 100 11.